Cost Benefits of Stepwise Addition of Prandial Insulin Aspart Compared to Full Basal-Bolus Therapy

被引：0
|
作者：
Saunders, Rhodri
Lian, Jean
Valentine, William
Karolicki, Boris
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1178-P
引用
收藏
页码：A306 / A307
页数：2
相关论文
共 50 条
  • [1] Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial
    Rodbard, Helena W.
    Visco, Virginia E.
    Andersen, Henning
    Hiort, Line C.
    Shu, David H. W.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (01): : 30 - 37
  • [2] Intensification of basal insulin therapy with step-wise addition of insulin aspart boluses compared with basal-bolus therapy: the FullSTEP study
    Rodbard, H.
    Visco, V. E.
    Andersen, H.
    Hiort, L. C.
    Shu, D. H. W.
    [J]. DIABETOLOGIA, 2013, 56 : S412 - S412
  • [3] Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial (vol 2, pg 30, 2014)
    Rodbard, H. W.
    Visco, V. E.
    Andersen, H.
    Hiort, L. C.
    Shu, D. H. W.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (01): : E3 - E3
  • [4] Stepwise intensification of prandial insulin versus basal-bolus insulin therapy in patients with type 2 diabetes mellitus
    Raccah, D.
    Haak, T.
    Huet, D.
    Monnier, L.
    Ramon, J. S.
    Robertson, D.
    Labard, P.
    Penfornis, A.
    [J]. DIABETOLOGIA, 2010, 53
  • [5] Intensification of Basal Insulin Therapy With Step-Wise Addition of Insulin Aspart Boluses vs. Basal-Bolus Therapy: The FullSTEP™ Study
    Rodbard, Helena W.
    Visco, Virginia E.
    Shu, David H. W.
    Andersen, Henning
    Hiort, Line C.
    Gross, Jorge L.
    [J]. DIABETES, 2013, 62 : A66 - A66
  • [6] Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: Results of the OSIRIS study
    Raccah, D.
    Haak, T. J.
    Huet, D.
    Monnier, L.
    Robertson, D.
    Labard, P.
    Soler, J.
    Penfornis, A.
    [J]. DIABETES & METABOLISM, 2012, 38 (06) : 507 - 514
  • [7] Intensive Insulin Therapy (Basal-Bolus)
    Chico, Ana
    Corcoy, Rosa
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (01) : E64 - E73
  • [8] Biphasic Insulin Aspart 30/70: Pharmacokinetics and Pharmacodynamics Compared With Once-Daily Biphasic Human Insulin and Basal-Bolus Therapy
    Heise, Tim
    Heinemann, Lutz
    Hovelmann, Ulrike
    Brauns, Bianca
    Nosek, Leszek
    Haahr, Hanne L.
    Olsen, Klaus J.
    [J]. DIABETES CARE, 2009, 32 (08) : 1431 - 1433
  • [9] Mealtime insulin aspart reduces the long-term cost of complications compared to human insulin as part of basal-bolus therapy in polish type 2 diabetes patients
    Goodall, G.
    Nielsen, S.
    Townsend, C.
    Kotchie, R.
    Erny-Albrecht, K.
    Valentine, W. J.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A265 - A265
  • [10] PRACTICAL ASPECTS OF BASAL-BOLUS INSULIN THERAPY
    BERGER, W
    SPINAS, GA
    [J]. THERAPEUTISCHE UMSCHAU, 1990, 47 (01) : 30 - 40
12345